Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





World’s First Online Image-Based COVID-19 Diagnosis Improvement Tool Launched

By LabMedica International staff writers
Posted on 03 Apr 2020
DetectED-X (Sydney, Australia), a University of Sydney spinoff comprising radiation and imaging experts, has launched the world’s only online image-based COVID-19 diagnosis improvement tool for healthcare workers. More...
The start-up has directed its breast cancer diagnosis tool at the coronavirus, drawing on pandemic cases globally with support from healthcare and industry leaders to ramp up COVID-19 detection. DetectED-X’s CovED platform, which can be accessed anywhere with an internet connection, is being provided for free and is supported by healthcare experts and leading corporations globally.

DetectED-X’s CovED follows on from the highly successful BreastScreen Reader Assessment Strategy (BREAST) platform, created in 2010 at the University of Sydney, which has been used internationally including in the US and Europe. The cloud-based life-saving technology can help doctors and radiologists diagnose cases faster and more accurately. Computed tomography (CT) lung scans, which produce cross-sectional images using X-rays and computers, are typically used after swabs are taken, to identify the extent and location of the disease; the CT scans produce images within minutes and are also able to diagnose COVID-19 in the very early stages that escape detection with nucleic acid tests.

DetectED-X’s approach, which includes algorithms to improve radiologist skills and identifying where errors were made on images in the online training sessions, has been shown to improve results significantly. Through CovED, individual clinicians can assess their performance on images on screen, and receive immediate feedback, including performance scores used in the industry. The image files personalized for each clinician are instantly returned showing any errors in their virtual diagnosis and the difficulty level is increased over time. As COVID-19 testing ramps up, the platform could facilitate rapid training where required – with modules able to be completed in as little as an hour – upskilling staff unfamiliar with lung radiology to prepare standardized reports for expert review.

“Our platform does not replace expert medical and radiologic training but CovED provides an effective way to recognize rapidly the appearances of COVID-19, which could be critical in a situation of too many patients and not enough expert radiologists, with the modules taking just 1-2 hours to complete,” said CEO Professor Patrick Brennan, medical radiation scientist and educator from the University of Sydney School of Health Sciences, Faculty of Medicine and Health. “This will be immediately crucial in developing countries, where numbers of radiologists are often insufficient – our tests will help people not only diagnose COVID-19 but also identify potentially life-threatening cases wherever they are.”

Related Links:
DetectED-X


Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers compared Huntington’s disease biomarkers in CSF and blood with clinical assessments and brain imaging to better understand changes before clinical onset (Image Credit: Adobe Stock)

Blood and Spinal Fluid Biomarker May Help Track Early Huntington’s Disease

Huntington’s disease is a genetic disorder caused by a mutation in the HTT gene that progressively affects movement, cognition, behavior, and independence. Although mutation carriers can be identified... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.